GLP-1R plays a central role in post-prandial insulin release [2]; the inhibition of gastric emptying [3, 4]; the inhibition of glucagon secretion [5] and the reduction of food intake [6], thus GLP-1R is an important pharmaceutical target for diabetes therapy. Here, GLP1R is linked to diabetes mellitus.